Literature DB >> 15759083

[Comparison of the minimal erythema dose for narrowband UV-B and broad spectrum UV-B using a new UV hand-held device].

M Lehnen1, M Koppermann, A Korber, S Grabbe, J Dissemond.   

Abstract

BACKGROUND: Phototherapy requires an individually adapted therapeutic regime that is based upon the minimal erythema dose for each patient. Whereas this is well established for UV-B broadband, so far no standardized equipment existed that allowed for determination of the MED for UV-B 311 nm narrowband irradiation. Thus, the starting dose for UV-B 311 nm is usually adjusted to the clinical skin type or the MED for broad-spectrum UV-B irradiation. PATIENTS AND METHODS: We determined the MED for UV-B 311 nm in a cohort of 110 healthy test persons with a newly constructed hand-held UV-light source and compared it to UV-B broadband MED.
RESULTS: For UV-B broadband, the MEDs ranged from 46.2 to 210.9 mJ/cm(2) with an average value of 108.45 mJ/cm(2). For the MED of narrowband UV-B 311 nm, the values ranged from 300.9 to 1.386.0 mJ/cm(2) with an average value of 838.88 mJ/cm(2). Concerning the factor of the MED UV-B broad-spectrum related to MED UV-B 311 nm narrowband, values from 4.01 to 13.68 with a average value of 7.91 resulted. No significant differences could be detected for the MED of UV-B broad-spectrum and narrowband in correlation to age, sex or clinical skin type.
CONCLUSION: Our data emphasize the presence of extensive inter-individual differences in the MED of both UV-B-spectra and point to the necessity to test patients before the first irradiation.

Entities:  

Mesh:

Year:  2005        PMID: 15759083     DOI: 10.1007/s00105-004-0854-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

Review 1.  [Narrow band UVB 311 nm versus broad band UVB. New developments in phototherapy].

Authors:  K Degitz; G Messer; G Plewig; M Röcken
Journal:  Hautarzt       Date:  1998-10       Impact factor: 0.751

2.  Narrow-band UVB phototherapy for severe atopic dermatitis.

Authors:  M J Hudson-Peacock; B L Diffey; P M Farr
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

3.  Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis.

Authors:  A Hofer; R Fink-Puches; H Kerl; P Wolf
Journal:  Br J Dermatol       Date:  1998-01       Impact factor: 9.302

4.  [UV-therapy of psoriasis. Half-side comparison between oral photochemotherapy (PUVA) and selective UV-phototherapy (SUP)].

Authors:  H Hönigsmann; P Fritsch; E Jaschke
Journal:  Z Hautkr       Date:  1977-11-01

5.  311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen.

Authors:  J Karvonen; E L Kokkonen; E Ruotsalainen
Journal:  Acta Derm Venereol       Date:  1989       Impact factor: 4.437

6.  The validity and practicality of sun-reactive skin types I through VI.

Authors:  T B Fitzpatrick
Journal:  Arch Dermatol       Date:  1988-06

7.  Action spectrum for phototherapy of psoriasis.

Authors:  J A Parrish; K F Jaenicke
Journal:  J Invest Dermatol       Date:  1981-05       Impact factor: 8.551

8.  Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris.

Authors:  I B Walters; L H Burack; T R Coven; P Gilleaudeau; J G Krueger
Journal:  J Am Acad Dermatol       Date:  1999-06       Impact factor: 11.527

9.  [Dithranol and combined treatment procedures: pro and con].

Authors:  G Mahrle; H J Schulze; G K Steigleder
Journal:  Hautarzt       Date:  1985-01       Impact factor: 0.751

10.  Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen?

Authors:  N J Wainwright; R S Dawe; J Ferguson
Journal:  Br J Dermatol       Date:  1998-09       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.